Get the Stockscreener App
33.22
0.75%
-0.25
After Hours:
33.89
0.67
+2.02%
Heartflow Inc stock is traded at $33.22, with a volume of 317.67K.
It is down -0.75% in the last 24 hours and down -0.48% over the past month.
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.
See More
Previous Close:
$33.47
Open:
$33.47
24h Volume:
317.67K
Relative Volume:
0.98
Market Cap:
$2.77B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-10.89%
1M Performance:
-0.48%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$33.00
$35.26
1-Week Range:
$32.70
$37.80
52-Week Range:
$28.27
$39.24
Heartflow Inc Stock (HTFL) Company Profile
Name
Heartflow Inc
Sector
Industry
Phone
650-241-1221
Address
331 E EVELYN AVENUE, MOUNTAIN VIEW
Compare HTFL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HTFL
Heartflow Inc
|
33.22 | 2.79B | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
286.09 | 46.97B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
94.47 | 16.75B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.50 | 12.29B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
93.23 | 7.80B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.16 | 6.81B | 906.14M | -52.62M | 89.62M | -0.3621 |
Heartflow Inc Stock (HTFL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-02-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | JP Morgan | Overweight |
| Sep-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Sep-02-25 | Initiated | Piper Sandler | Overweight |
| Sep-02-25 | Initiated | Stifel | Buy |
Heartflow Inc Stock (HTFL) Latest News
HTFL Stock Price and Chart — NASDAQ:HTFL - TradingView
Heartflow (NASDAQ:HTFL) Sets New 12-Month HighShould You Buy? - MarketBeat
HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis - Yahoo Finance
Heartflow, Inc. (NASDAQ:HTFL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Why HeartFlow Stock Rocketed 14% Higher Today - MSN
Heartflow receives FDA clearance for updated plaque analysis platform - MedTech Dive
FDA clears Heartflow’s next-gen plaque analysis - BioWorld MedTech
Heartflow (NASDAQ:HTFL) Shares Up 10% Following Analyst Upgrade - MarketBeat
CCORF Maintains Heartflow(HTFL.US) With Buy Rating, Maintains Target Price $39 - 富途牛牛
Heartflow secures FDA clearance for updated plaque analysis platform - Yahoo Finance
Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform - BioSpace
Heartflow (NASDAQ:HTFL) Given New $39.00 Price Target at Canaccord Genuity Group - Defense World
FDA clears Heartflow’s AI plaque analysis tool, Cigna to cover it - Investing.com
FDA clears Heartflow’s AI plaque analysis tool, Cigna to cover it By Investing.com - Investing.com South Africa
Heartflow stock rises after FDA clearance for Next Gen Plaque Analysis By Investing.com - Investing.com Nigeria
Heartflow stock rises after FDA clearance for Next Gen Plaque Analysis - Investing.com Nigeria
Heartflow announces FDA 510(k) clearance and launch of next generation Heartflow Plaque Analysis platform - MarketScreener
Heartflow Announces FDA 510(K) Clearance And Launch Of Next Generation Heartflow Plaque Analysis Platform - TradingView
Heartflow Receives FDA 510(k) Clearance for Next-Gen Heartflow Plaque Analysis Platform - MarketScreener
Cigna (CI) to Cover Heartflow's Newly Approved Technology - GuruFocus
FDA Clears Heartflow Coronary Plaque Technology - MarketScreener
Heartflow announces FDA clearance of plaque analysis algorithm, Cigna coverage - TipRanks
95% Accuracy vs Gold Standard: HeartFlow's Revolutionary AI Heart Disease Platform Wins FDA Approval - Stock Titan
Heartflow (NASDAQ:HTFL) Stock Price Down 5.2% After Earnings Miss - MarketBeat
Canaccord Genuity raises Heartflow stock price target to $39 on FFRct growth - Investing.com Nigeria
Canaccord Genuity Group Issues Positive Forecast for Heartflow (NASDAQ:HTFL) Stock Price - MarketBeat
Heartflow price target raised to $39 from $35 at Canaccord - TipRanks
Heartflow (NASDAQ:HTFL) Announces Quarterly Earnings Results - MarketBeat
AI-Enabled Heart Diagnostics Put HeartFlow (HTFL) in the Spotlight - MSN
HeartFlow: Q2 Earnings Snapshot - New Haven Register
HeartFlow, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Heartflow, Inc. SEC 10-Q Report - TradingView
Stocks Generating Improved Relative Strength: Heartflow - MSN
Heartflow Completes US$364 Million Upsized IPO - Global Legal Chronicle
Heartflow, Inc.'s (NASDAQ:HTFL) Quiet Period Will Expire on September 17th - MarketBeat
HeartFlow, Inc.: Balancing Impressive Growth with Strategic Challenges – A Hold Recommendation - TipRanks
Heartflow (NASDAQ:HTFL) Shares Gap UpHere's Why - MarketBeat
HeartFlow Releases Investor Presentation at Healthcare Conference - TipRanks
Heartflow Incexpects Q2 2025 revenue of $43.4 millionSEC filing - MarketScreener
HeartFlow (HTFL): Evaluating Valuation After Recent Share Price Surge Without a Clear Catalyst - Yahoo Finance
Heartflow Inc Stock (HTFL) Financials Data
There is no financial data for Heartflow Inc (HTFL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):